posttransplant cyclophosphamide
Showing 1 - 25 of 1,955
Graft Vs Host Disease, Hematopoietic Tumor Trial in Brazil (Methotrexate Injectable Solution)
Recruiting
- Graft Vs Host Disease
- Hematopoietic Neoplasm
- Methotrexate Injectable Solution
-
Rio De Janeiro, RJ, Brazil
- +3 more
Sep 10, 2021
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,
Completed
- Myelodysplastic Syndrome
- +13 more
- Fludarabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined
Completed
- Posttransplant Lymphoproliferative Disorder
- Rituximab sc
- +3 more
-
Aachen, Germany
- +17 more
Aug 22, 2022
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2023
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022
GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)
Recruiting
- GATA2
- +2 more
- Allogeneic HSCT
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Urinary Tract Infections, Transplant-Related Disorder Trial in Tehran (Phage)
Recruiting
- Urinary Tract Infections
- Transplant-Related Disorder
- Phage
-
Tehran, Iran, Islamic Republic ofNooshin Dalili
Jul 21, 2023
T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run
Completed
- T-Cell Peripheral Lymphoma
- +3 more
- Rituximab
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021
Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)
Active, not recruiting
- Sickle Cell Anemia
- PBSC Transplant
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022
Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)
Recruiting
- Advanced Melanoma
- Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
-
Basel, SwitzerlandDivision of Medical Oncology and Cancer Immunology, University H
Aug 3, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Cyclophosphamide
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 20, 2023
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021
Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)
Active, not recruiting
- Neuroblastoma
- Sorafenib
- +2 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)
Recruiting
- Breast Cancer
- Pegylated liposomal doxorubicin
- +5 more
-
Shanghai, ChinaShanghai Pudong Hospital
Dec 11, 2022
Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)
Not yet recruiting
- Peripheral T Cell Lymphoma
- CHOP+selinexor+5-Azacitidine
- +2 more
- (no location specified)
Dec 29, 2022
Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)
Not yet recruiting
- Relapsed/Refractory Large B Cell Lymphoma
- ALLO-647
- +3 more
- (no location specified)
Feb 6, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (lenalidomide, Placebo, Rituximab)
Completed
- Lymphoma, Large B-Cell, Diffuse
- lenalidomide
- +6 more
-
Fayetteville, Arkansas
- +431 more
Nov 17, 2022
Hyperspectral Imaging Technique in CTX Treatment of IMN
Not yet recruiting
- Hyperspectral Imaging
- +2 more
- Microscopic hyperspectral imaging system
- (no location specified)
Apr 29, 2023